RIM
CRL icon

RS Investment Management’s Charles River Laboratories CRL Stock Holding History

RS Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-157,265
Closed -$12.5M – 358
2015
Q1 		$12.5M Sell
157,265
-226,930
-59% -$16.7M 0.11% 224
2014
Q4 		$24.4M Sell
384,195
-201,695
-34% -$12.6M 0.22% 162
2014
Q3 		$35M Sell
585,890
-30,025
-5% -$1.72M 0.32% 111
2014
Q2 		$33M Sell
615,915
-31,410
-5% -$1.72M 0.28% 127
2014
Q1 		$39.1M Sell
647,325
-41,925
-6% -$2.44M 0.23% 136
2013
Q4 		$36.6M Sell
689,250
-7,511
-1% -$377K 0.22% 141
2013
Q3 		$32.2M Sell
696,761
-7,964
-1% -$365K 0.21% 141
2013
Q2 		$28.9M Buy
+704,725
New +$30.2M 0.21% 132

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RS Investment Management's CRL Position: Q2 2015 in Review

RS Investment Management sold out of Charles River Laboratories (CRL) in Q2 2015, closing a stake of 157,265 shares — an estimated $12.5M sold.

RS Investment Management first reported a position in CRL in Q2 2013 and held it in 8 quarters. The position peaked at $39.1M in Q1 2014. 261 funds tracked by Wall St. Rank hold CRL as of Q2 2015.

  • RS Investment Management reported no remaining Charles River Laboratories position as of Q2 2015 after selling out during the quarter.
  • RS Investment Management sold 157,265 Charles River Laboratories shares in Q2 2015, an estimated $12.5M.
  • RS Investment Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 8 quarters.
  • RS Investment Management's Charles River Laboratories position peaked at $39.1M in Q1 2014.
  • 261 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2015.

Based on RS Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.